Endothelin receptor agonists and antagonists exhibit different dissociation characteristics.
Endothelins (ETs) are vasoconstricting peptides that bind to membrane receptors to initiate their physiological effects. This report compares the dissociation characteristics of selected ET agonists and antagonists, and studies the effects of any difference in dissociation characteristics on the potency of antagonists. Competition studies using various ET receptor ligands against [125I]ET-1 or [125I]ET-3 binding demonstrated that porcine cerebellum membranes contain predominantly ETB receptor. [125I]IRL1620 associated with the receptors in a time-dependent manner. Although bound [125I]IRL1620 was easier to dissociate than bound [125I]ET-3, both agonists exhibited a dissociation half life > 20 h. For non-radiolabeled ligands, bind-and-wash studies were employed in which membranes were pre-incubated with unlabeled ligand followed by extensive washing before assaying for [125I]ET-1 binding. Results from bind-and-wash studies confirmed that bound non-radiolabeled IRL1620 and ET were as difficult to dissociate as [125I]ligands. In contrast, bound PD142893 and Ro46-2005 were easily dissociated from ETB receptors. Consequently, the inhibitory effects of PD142893 and Ro46-2005 on [125I]agonist binding diminished following incubation time. In cloned human ETA and ETB receptors, bound ET-1 was also more difficult to dissociate than bound antagonists. These results suggest that the differences in the dissociation characteristics of ET receptor agonists vs. antagonists may account for the diminished potency of Ro46-2005 and PD142893 as a function of incubation time.
Wu-Wong
J R
JR
Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064.
Chiou
W J
WJ
Magnuson
S R
SR
Opgenorth
T J
TJ
D000595:Amino Acid Sequence; D000818:Animals; D001667:Binding, Competitive; D001923:Brain Chemistry; D016466:CHO Cells; D006224:Cricetinae; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000737:chemistry / Q000378:metabolism*; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000494:pharmacology; D010446:Peptide Fragments / Q000378:metabolism; D011743:Pyrimidines / Q000494:pharmacology; D017466:Receptors, Endothelin / Q000819:agonists* / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology; D013552:Swine; D000096926:Benzenesulfonamides
D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D009842:Oligopeptides; D010446:Peptide Fragments; D011743:Pyrimidines; D017466:Receptors, Endothelin; D013449:Sulfonamides; C074308:sovateltide; C076213:PD 142893; C083751:Ro 46-2005; D000096926:Benzenesulfonamides